Remove Biosimilars Remove Pharmaceutical Companies Remove Vaccines
article thumbnail

STAT+: Pharmalittle: WHO pandemic accord may force pharma to disclose prices; FDA OKs first therapy to delay type 1 diabetes

STAT

Pharmaceutical companies could be made to disclose prices and deals for products they make to fight future global health emergencies, under new rules that would govern a World Health Organization-backed pandemic accord , Reuters reports.  A Or you may want to take stock of your life. But be safe. Enjoy, and see you soon.

Diabetes 242
article thumbnail

TÜBITAK, MAM to produce drugs and vaccines on pilot scale in Türkiye

Pharmaceutical Business Review

Located at the TÜBITAK MAM Gebze campus in Kocaeli province close to Istanbul, the MEDIBIYO facility can generate biotechnological drugs and vaccines that align with good manufacturing practice (GMP) standards, stated the Turkish publication. MEDIBIYO is expected to begin operations to meet demands of the pharmaceutical companies.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

TÜBITAK, MAM to produce drugs and vaccines on pilot scale in Türkiye

Pharma Leaders

Marmara Research Center (MAM) and The Scientific and Technological Research Council of Türkiye (TÜBITAK) have commenced Medical Biotechnology Research Center (MEDIBIYO) for the production of drugs and vaccines on a pilot scale, reported Daily Sabah. MEDIBIYO is expected to begin operations to meet demands of the pharmaceutical companies.

article thumbnail

Market cap growth surges for over half of the top biopharmaceutical companies in 2022

Pharmaceutical Technology

The 13 top players experienced significant growth over 2022 despite the decline in demand for COVID-19 vaccines and therapeutics, as well as uncertainty surrounding pricing due to the newly passed Inflation Reduction Act in the US. billion between Dec 31, 2021 and Dec 31, 2022, owing to expansion in its vaccine and oncology portfolio.

article thumbnail

Pharma sector awaits Budget 2024 for innovation boost and regulatory reforms

Express Pharma

The government’s initiative to implement a draft strategy aimed at promoting innovation, R&D, and industry-led innovation growth in India’s MedTech and Pharmaceutical industries is a welcome move. This would stimulate new investments in both R&D and production initiatives.

article thumbnail

Pharma sector reels as UK Government doubles VPAS payback rate on NHS drugs

Pharmaceutical Technology

At this punitive percentage, VPAS member companies may be required to pay back up to GBP3.3 Pushback from the industry Responses from pharmaceutical companies since December’s announcement of the payback hike have been swift and cutting. For 2019–23, this was capped at 2% per year. billion ($4.1 billion) to the NHS.

article thumbnail

IN FOCUS: Solvias

Pharmaceutical Technology

Pharmaceutical Technology Excellence Rankings – The Verdict. Solvias is a Swiss-based pharmaceutical company focused on contract research, development and manufacturing. The company is ranked in the M&A, PRODUCT LAUNCHES and RESEARCH AND DEVELOPMENT categories in the 2022 Pharmaceutical Technology Excellence Rankings.